Skip to Content

Nichi-Iko Pharmaceutical Co Ltd NHKFF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Nichi-Iko Pharmaceutical Co Ltd is a major drug manufacturing company in Japan. Its core business includes the manufacture and sale of generic pharmaceutical products, through sales to pharmaceutical wholesalers and medical institutions. The vast majority of the company's sales are derived from prescription drugs. The company operates various subsidiaries across an array of other countries, including Thailand.

Contact
1-chome, 6-21 Sokuma, Toyama-shi
Toyama, 930-8583, Japan
T +81 764322121
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2020
Fiscal Year End Mar 31, 2020
Stock Type
Employees 2,639